Fresenius is expanding its biosimilar manufacturing strategy through a WuXi Biologics partnership, gaining access to 37 candidates and strengthening its long-term biopharma ambitions.
Patan's new cancer hospital adds Rs 22 crore radiotherapy capacity and free PET scans for eligible beneficiaries, raising hopes of better regional cancer care access.
RPG Life Sciences' 500 crore acquisition bet could redefine its API business, expand manufacturing capacity and accelerate export growth.
Haryana's Private Healthcare Integration challenge highlights the gap between public healthcare mapping and private-sector participation in India's expanding digital health infrastructure.
Weight loss injections may ease PMOS symptoms and improve metabolic health, but experts warn they cannot cure underlying hormonal imbalances.
Sun Pharma gains CDSCO approval for oral semaglutide tablets, marking its entry into India’s competitive oral GLP-1 market.
Sun Pharma’s Q2 profit falls as acquisition costs rise, despite revenue growth and stronger operating performance across key business segments.
India's healthcare industry faces three defining shifts as drug pricing, weight-loss innovation, and pharmaceutical R&D reshape patient access and competition.
Omron's Chennai factory puts medical device localization in focus as India seeks domestic production, component sourcing and a larger role in global healthcare supply chains.
Patient accommodation infrastructure is gaining attention as AIIMS Delhi prepares to use BEL's new 897-seat facility to improve support for patients and attendants.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")
